donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02142 HBM HOLDINGS-B > Detailed Quotes

02142 HBM HOLDINGS-B

4.070
-0.030-0.73%
Market Close 06/30 16:08 CCT
High
4.200
Open
4.050
Turnover
6.88M
Low
4.000
Pre Close
4.100
Volume
1.69M
Market Cap
3.13B
P/E(TTM)
Loss
52wk High
10.500
Shares
767.89M
P/E(Static)
Loss
52wk Low
3.080
Float Cap
3.13B
Bid/Ask %
-3.59%
Historical High
12.400
Shs Float
767.89M
Volume Ratio
0.45
Historical Low
3.080
Dividend TTM
--
Div Yield TTM
--
P/B
1.80
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.22%
Amplitude
4.88%
Avg Price
4.067
Lot Size
1000
Float Cap
3.13B
Bid/Ask %
-3.59%
Historical High
12.400
Shs Float
767.89M
Volume Ratio
0.45
Historical Low
3.080
Dividend TTM
--
P/B
1.80
Dividend LFY
--
Turnover Ratio
0.22%
Amplitude
4.88%
Avg Price
4.067
Lot Size
1000
Price Forecast

No Data

News

Comment

No More
Company Overview More
Heplatinum Pharmaceutical Holdings Co., Ltd. is an investment holding company mainly engaged in the development of innovative therapies in the field of tumor immunology and immune diseases. The company's products include bartolizumab, mainly for immune thrombocytopenia, thyroid associated ophthalmopathy, myasthenia gravis, optic neuromyelitis spectrum diseases, and tenacil, mainly for dry eye diseases. In addition, the company also studies and develops tumor immunization product lines, including internally developed new-generation tumor immune assets for the treatment of immune desert, immune rejection and inflammatory tumors.
CEO: Jingsong Wang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...